Scientists Develop Simple Test That Detects 95% of a Common Cancer in Study
Summary
Researchers at Stanford University have created a new urine test called uRARE-seq that detects bladder cancer by measuring RNA in urine. The test correctly identified bladder cancer in 95% of cases in a study and can also help doctors monitor treatment and choose the best therapy for patients.Key Facts
- Bladder cancer affects about 85,000 people in the U.S. each year.
- Current diagnosis methods can miss about 30% of cancer cases.
- The new test detects RNA messages released by tumor cells in urine.
- RNA testing shows which cancer genes are active, helping to understand tumor behavior.
- The test was 95% accurate in detecting bladder cancer and 90% accurate in ruling it out.
- It can detect early and less aggressive bladder cancers.
- The test helps monitor leftover cancer after surgery and BCG immunotherapy treatment.
- More studies are needed to confirm if it allows earlier diagnosis and improves patient care.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
